European Academy of Neurology (EAN 2026)

Geneva, Switzerland
|
June 27 - 30, 2026
Focus: 
Myasthenia Gravis (MG)
Location: 
S04

Publication To Be Presented

A Phase 3 Study to Evaluate the Efficacy and Safety of Telitacicept in Patients With Generalized Myasthenia Gravis: Trial Design Update